Project Description

Product description

Pidotimod is the first compound of a new class of modifiers of biological responses, with a peptide-like structure obtained by synthesis, which is well characterized and chemically pure. Furthermore, pidotimod shows a high oral bioavailability.

The drug has proven to be active on the aspecific and the specific components of immune response.


Immuno-correcting therapy of bacterial, fungous and viral infection of upper and lower airways and urinary tracts, as part of complex therapy.